Ovulant 50mg Tablet Philippines - English - FDA (Food And Drug Administration)

ovulant 50mg tablet

totalcare pharma inc - clomifene citrate - tablet - 50mg

Ovulant 50 mg Tablet Philippines - English - FDA (Food And Drug Administration)

ovulant 50 mg tablet

aldril pharmaceuticals, inc. - clomifene citrate - tablet - 50 mg

Solcovagin 537mg/ml+20,4mg/ml+58,6mg/ml+6mg/ml solution for topical use Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

solcovagin 537mg/ml+20,4mg/ml+58,6mg/ml+6mg/ml solution for topical use

legacy pharmaceuticals switzerland gmbh - nitric acid 70%, glacial acetic acid, oxalic acid dihydrate, zinc nitrate hexahydrate - solution for topical use - 537mg/ml+20,4mg/ml+58,6mg/ml+6mg/ml

Solcovagin solution for topical use Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

solcovagin solution for topical use

legacy pharmaceuticals switzerland gmbh - nitric acid 70%, glacial acetic acid, oxalic acid dihydrate, zinc nitrate hexahydrate - solution for topical use - 537mg/ml+ 20,4mg/ml+ 58,6mg/ml+ 6mg/ml

OVUPLANT Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ovuplant

virbac (australia) pty ltd - deslorelin as deslorelin acetate - parenteral implant, device - deslorelin as deslorelin acetate ungrouped active 2.1 mg/im - endocrine system - horse mare (female) | female horse - induction of ovulation

OVESTIN OVULA 0.5mg pessary strip pack Australia - English - Department of Health (Therapeutic Goods Administration)

ovestin ovula 0.5mg pessary strip pack

aspen pharmacare australia pty ltd - estriol, quantity: 0.5 mg - pessary, moulded - excipient ingredients: hard fat; cetomacrogol 1000; glyceryl ricinoleate - vulvo-vaginal complaints due to oestrogen deficiency associated with the climacteric and the postmenopause or after ovariectomy - atrophic vaginitis; - pruritus vulvae; - dyspareunia due to vulvo-vaginal atrophy; - as auxillary therapy in the treatment of vaginal infections - as pre-operative therapy for vulvo-vaginal surgery and during subsequent convalescence; - ulcers in cases of prolapse of the uterus or vagina; - to avoid misinterpretation of a cytological smear.

Ovitrelle European Union - English - EMA (European Medicines Agency)

ovitrelle

merck europe b.v. - choriogonadotropin alfa - anovulation; reproductive techniques, assisted; infertility, female - sex hormones and modulators of the genital system, - ovitrelle is indicated in the treatment of:women undergoing superovulation prior to assisted reproductive techniques such as in vitro fertilisation (ivf): ovitrelle is administered to trigger final follicular maturation and luteinisation after stimulation of follicular growth;anovulatory or oligo-ovulatory women: ovitrelle is administered to trigger ovulation and luteinisation in anovulatory or oligo-ovulatory patients after stimulation of follicular growth.